Evolus to Participate in Two Upcoming Investor Conferences

IRVINE, Calif., June 14, 2018 (GLOBE NEWSWIRE) — Evolus, Inc. (“Evolus”) (NASDAQ:EOLS), a premiere aesthetics company, announced today that members of management will be participating in two upcoming investor conferences in New York, NY.

           
      Event:   Cantor 2018 Dermatology & Aesthetics Summit
      Panel:   Novel Aesthetic Dermatology Drugs and Devices for Unmet Needs
      Date:   Tuesday, June 19, 2018 
      Time:   12:00 p.m. ET
      Location:   The Westin New York Grand Central, New York
           
           
      Event:   JMP Securities Life Sciences Conference
      Date:   Wednesday, June 20, 2018
      Time:   9:00 a.m. ET
      Location:   The St. Regis, New York
           

An audio webcast of the Company’s presentation at the JMP Securities Life Sciences Conference will be available on the investor relations section of Evolus’ website at investors.evolus.com. Replays of the webcast will be available for 90 days after the date of the presentation.

About Evolus, Inc.

Evolus is a premiere aesthetics company focused on providing physicians and their patients with expanded choices in aesthetic treatments and procedures.  Evolus’ lead product candidate DWP-450, also known by the chemical name prabotulinumtoxinA, is a 900 kDa purified botulinum toxin type A complex that is being evaluated for the treatment of moderate to severe glabellar lines in adult patients.

Evolus Contacts:

Investor Contact:
Brian Johnston, The Ruth Group
Tel: +1 646-536-7028
Email: IR@Evolus.com

Media Contact:
Kirsten Thomas, The Ruth Group
Tel: +1-508-280-6592
Email: kthomas@theruthgroup.com

http://globenewswire.com/news-release/2018/06/14/1524572/0/en/Evolus-to-Participate-in-Two-Upcoming-Investor-Conferences.html

Author: Stocks News Feed

Welcome to Stocks News Feed, Join the Conversation. Don't forget to Share if you like an article.

Leave a Reply

Your email address will not be published. Required fields are marked *